John M Siebert - Net Worth and Insider Trading

John M Siebert Net Worth

The estimated net worth of John M Siebert is at least $445,165 dollars as of 2024-04-26. John M Siebert is the Director of Supernus Pharmaceuticals Inc and owns about 15,188 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $445,160. John M Siebert is also the Director of Aradigm Corp and owns about 100 shares of Aradigm Corp (ARDMQ) stock worth over $5. Details can be seen in John M Siebert's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John M Siebert has not made any transactions after 2013-03-21 and currently still holds the listed stock(s).

Transaction Summary of John M Siebert

To

John M Siebert Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John M Siebert owns 2 companies in total, including Supernus Pharmaceuticals Inc (SUPN) , and Aradigm Corp (ARDMQ) .

Click here to see the complete history of John M Siebert’s form 4 insider trades.

Insider Ownership Summary of John M Siebert

Ticker Comapny Transaction Date Type of Owner
SUPN Supernus Pharmaceuticals Inc 2013-12-12 director
ARDMQ Aradigm Corp 2018-03-22 director & Interim Principal Exec Ofcr

John M Siebert Latest Holdings Summary

John M Siebert currently owns a total of 2 stocks. Among these stocks, John M Siebert owns 15,188 shares of Supernus Pharmaceuticals Inc (SUPN) as of March 21, 2013, with a value of $445,160 and a weighting of 100%. John M Siebert also owns 100 shares of Aradigm Corp (ARDMQ) as of November 3, 2006, with a value of $5 and a weighting of 0%.

Latest Holdings of John M Siebert

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SUPN Supernus Pharmaceuticals Inc 2013-03-21 15,188 29.31 445,160
ARDMQ Aradigm Corp 2006-11-03 100 0.05 5

Holding Weightings of John M Siebert


John M Siebert Form 4 Trading Tracker

According to the SEC Form 4 filings, John M Siebert has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the acquisition of 3,000 shares on March 21, 2013, which cost John M Siebert around $16,500.

According to the SEC Form 4 filings, John M Siebert has made a total of 0 transactions in Aradigm Corp (ARDMQ) over the past 5 years. The most-recent trade in Aradigm Corp is the sale of 0 shares on November 3, 2006, which brought John M Siebert around $0.

Insider Trading History of John M Siebert

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John M Siebert Trading Performance

GuruFocus tracks the stock performance after each of John M Siebert's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John M Siebert is 36.26%. GuruFocus also compares John M Siebert's trading performance to market benchmark return within the same time period. The performance of stocks bought by John M Siebert within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John M Siebert's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John M Siebert

Average Return

13.67%

Average return per transaction

Outperforming Transactions

33%

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.71 36.26 35.62 13.67 21.72 30.53
Relative Return to S&P 500(%) -9.11 31.92 25.67 -8.36 3.25 17.33

John M Siebert Ownership Network

Ownership Network List of John M Siebert

No Data

Ownership Network Relation of John M Siebert


John M Siebert Owned Company Details

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

John M Siebert is the director of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, John M Siebert made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

John M Siebert Mailing Address

Above is the net worth, insider trading, and ownership report for John M Siebert. You might contact John M Siebert via mailing address: 1000 Valley View Road, Eden Prairia Mn 65344.

Discussions on John M Siebert

No discussions yet.